# Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study

> **NCT06947265** · PHASE4 · COMPLETED · sponsor: **Fayoum University Hospital** · enrollment: 180 (actual)

## Conditions studied

- Erectile Dysfunctions

## Interventions

- **DRUG:** L-Arginine
- **DRUG:** Tadalafil 5 mg

## Key facts

- **NCT ID:** NCT06947265
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-14
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947265, "Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06947265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*